Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorMANSFIELD, A. S.
dc.contributor.authorHERBST, R. S.
dc.contributor.authorCASTRO JR., G.
dc.contributor.authorHUI, R.
dc.contributor.authorPELED, N.
dc.contributor.authorKIM, D-W.
dc.contributor.authorNOVELLO, S.
dc.contributor.authorSATOUCHI, M.
dc.contributor.authorWU, Y-L.
dc.contributor.authorGARON, E. B.
dc.contributor.authorRECK, M.
dc.contributor.authorROBINSON, A. G.
dc.contributor.authorSAMKARI, A.
dc.contributor.authorPIPERDI, B.
dc.contributor.authorEBIANA, V.
dc.contributor.authorLIN, J.
dc.contributor.authorMOK, T. S. K.
dc.identifier.citationANNALS OF ONCOLOGY, v.30, suppl.5, p.604-606, 2019
dc.description.sponsorshipMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA
dc.publisherOXFORD UNIV PRESSeng
dc.relation.ispartofAnnals of Oncology
dc.titleOutcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1-positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001,-010,-024, and-042eng
dc.rights.holderCopyright OXFORD UNIV PRESSeng
dc.description.conferencedateSEP 27-OCT 01, 2019
dc.description.conferencelocalBarcelona, SPAIN
dc.description.conferencename44th Congress of the European-Society-for-Medical-Oncology (ESMO)
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng, A. S.:Mayo Clin, Div Med Oncol, Rochester, MN USA, R. S.:Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT USA, R.:Univ Sydney, Westmead Hosp, Sydney, NSW, Australia, N.:Ben Gurion Univ Negev, Soroka Canc Ctr, Beer Sheva, Israel, D-W.:Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea, S.:Univ Turin, Azienda Osped Univ San Luigi Gonzaga, Orbassano, Italy, M.:Hyogo Canc Ctr, Med Oncol, Akashi, Hyogo, Japan, Y-L.:Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China; Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China, E. B.:Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA, M.:German Ctr Lung Res, Lung Clin Grosshansdorf, Airway Res Ctr North, Grosshansdorf, Germany, A. G.:Kingston Gen Hosp, Dept Oncol, Canc Ctr Southeastern Ontario, Kingston, ON, Canada, A.:Merck & Co Inc, Oncol Clin Dev, Kenilworth, NJ USA, B.:Merck & Co Inc, Oncol Clin Dev, Kenilworth, NJ USA, V.:Merck & Co Inc, Oncol Clin Dev, Kenilworth, NJ USA, J.:Merck & Co Inc, Oncol Clin Dev, Kenilworth, NJ USA, T. S. K.:Chinese Univ Hong Kong, State Key Lab South China, Hong Kong, Peoples R China
hcfmusp.description.issuesuppl 5
Appears in Collections:

Comunicações em Eventos - FM/MDR
Departamento de Radiologia - FM/MDR

Comunicações em Eventos - HC/ICESP
Instituto do Câncer do Estado de São Paulo - HC/ICESP

Comunicações em Eventos - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.